我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.
相关临床试验
0
0 进行中
药物批准
批准总数
监管机构
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无批准数据
- REPROCELL has launched a comprehensive GMP Master Cell Bank manufacturing service for clinical-grade induced pluripotent stem cells from its Maryland facility, offering end-to-end workflow capabilities. - The platform includes the StemRNA Clinical iPSC Seed Clone LLF-34-F3, derived from US donor material and supported by an active FDA Drug Master File. - The integrated service spans donor screening, iPSC manufacturing, gene editing, and GMP banking to accelerate IND submissions for cell therapy developers. - REPROCELL also provides European manufacturing alignment through partner Histocell, operating under EMA oversight and Spanish regulatory authorization.
